> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Fresenius NDA for Voluven Withdrawn
- URL: https://www.fdaweb.com/fresenius-nda-for-voluven-withdrawn/
- Published: 2021-12-09T12:00:00.000Z
- Updated: 2026-09-14T17:25:13.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5150734

*Federal Register* notice: FDA is withdrawing approval of a Fresenius Kabi NDA for Voluven (6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection). The company notified the agency that the product is no longer marketed. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2021-12-09/pdf/2021-26648.pdf?ref=fdaweb.com).